VitaNova Life Sciences (VNOV) Other Operating Expenses (2017 - 2026)

VitaNova Life Sciences has disclosed Other Operating Expenses across 4 years of filings, most recently posting $37852.0 for Q3 2026.

• Other Operating Expenses for Q3 2026 came in at $37852.0, up 8.37% year-over-year; the trailing twelve-month figure through Jul 2026 was $176118.0 (down 3.86% YoY), and the FY2026 annual result was $173193.0, down 17.24% from the prior year.
• Other Operating Expenses for Q3 2026 stood at $37852.0, down from $46065.0 in the prior quarter.
• Across five years, Other Operating Expenses topped out at $85329.0 in Q2 2024 and bottomed at $34928.0 in Q3 2025.
• Average Other Operating Expenses over 3 years is $50564.9, with a median of $47918.0 recorded in 2025.
• The widest annual swing landed in 2025, when Other Operating Expenses sank 46.84%; it then advanced 8.37% in 2026.
• Year by year, Other Operating Expenses stood at $53127.0 in 2024, then decreased by 20.59% to $42189.0 in 2025, then dropped by 10.28% to $37852.0 in 2026.
• The last three Other Operating Expenses figures came in at $37852.0 (Q3 2026), $46065.0 (Q2 2026), and $50012.0 (Q1 2026), per Business Quant data.